EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

First case report of hypouricemia associated with adjuvant imatinib therapy in a patient with small intestinal gastrointestinal stromal tumor

Juan Bu, Yeledan Mahan, Reziwanguli Yuemaier, Xiaoling Zhang, Ling Zhou

Frontiers in Oncology · 20.05.2026 · 16

DOI: 10.3389/fonc.2026.1765401 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 20.05.2026. Verfasst von Juan Bu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research and Translational Management, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Imatinib, a tyrosine kinase inhibitor, is primarily used for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors (GIST). The most common adverse events include peripheral edema, mild nausea, vomiting, diarrhea, myalgia, muscle cramps, and skin rash. In patients with GIST receiving imatinib therapy, routine laboratory tests typically reveal hematologic abnormalities such as decreased hemoglobin, erythrocyte, neutrophil, and platelet counts, alongside elevated hepatic transaminase levels. However, to our knowledge, no cases of imatinib-associated hypouricemia have been reported. Here, we present a case of hypouricemia temporally associated with adjuvant imatinib therapy in a patient with intestinal GIST. This case highlights the importance for clinicians to be aware of hypouricemia as a potential adverse event during imatinib therapy.

Schlagwörter

Stichwörter der Autor:innen

GISTadverse eventhypouricemiaimatinibtyrosine kinase inhibitor

Autor:innen und Institutionen

  • Department of Medical Research and Translational Management, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.

Zitieren

APA

Bu, J., Mahan, Y., Yuemaier, R., Zhang, X., & Zhou, L. (2026). First case report of hypouricemia associated with adjuvant imatinib therapy in a patient with small intestinal gastrointestinal stromal tumor. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1765401

Vancouver

Bu J, Mahan Y, Yuemaier R, Zhang X, Zhou L. First case report of hypouricemia associated with adjuvant imatinib therapy in a patient with small intestinal gastrointestinal stromal tumor. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1765401

BibTeX
@article{Bu2026,
  author = {Bu, Juan and Mahan, Yeledan and Yuemaier, Reziwanguli and Zhang, Xiaoling and Zhou, Ling},
  title = {First case report of hypouricemia associated with adjuvant imatinib therapy in a patient with small intestinal gastrointestinal stromal tumor},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1765401}
}
Kostenlos starten →